Stock 002755 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Beijing Aosaikang Pharmaceutical Co., Ltd.

Equities

002755

CNE100001X92

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
9.65 CNY -0.62% Intraday chart for Beijing Aosaikang Pharmaceutical Co., Ltd. -3.31% -10.81%
10/05 Aosaikang Pharma's Unit Gets Nod to Market Isavuconazole Sulfate for Injection MT
28/04 Beijing Aosaikang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2024 2025 2026
Capitalization 1 12,122 11,815 8,957 - -
Enterprise Value (EV) 1 12,122 11,815 8,957 8,957 8,957
P/E ratio 16.7 x 31 x 322 x 80.4 x 46 x
Yield - - - - -
Capitalization / Revenue 3.21 x - 5.26 x 4.64 x 4 x
EV / Revenue 3.21 x - 5.26 x 4.64 x 4 x
EV / EBITDA 13.7 x - 140 x 53 x 33.9 x
EV / FCF - - -114 x 210 x 72.1 x
FCF Yield - - -0.88% 0.48% 1.39%
Price to Book 3.99 x - 3.05 x 2.94 x 2.79 x
Nbr of stocks (in thousands) 9,28,160 9,28,160 9,28,160 - -
Reference price 2 13.06 12.73 9.650 9.650 9.650
Announcement Date 17/02/21 29/04/22 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2024 2025 2026
Net sales 1 3,781 - 1,703 1,929 2,242
EBITDA 1 882.9 - 64 169 264
EBIT 1 811.4 - 33 152 263
Operating Margin 21.46% - 1.94% 7.88% 11.73%
Earnings before Tax (EBT) 1 832.2 - 39 160 274
Net income 1 727.3 379.9 29 114 193
Net margin 19.24% - 1.7% 5.91% 8.61%
EPS 2 0.7800 0.4100 0.0300 0.1200 0.2100
Free Cash Flow 1 - - -78.39 42.69 124.2
FCF margin - - -4.6% 2.21% 5.54%
FCF Conversion (EBITDA) - - - 25.26% 47.03%
FCF Conversion (Net income) - - - 37.45% 64.33%
Dividend per Share - - - - -
Announcement Date 17/02/21 29/04/22 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - - -78.4 42.7 124
ROE (net income / shareholders' equity) 26.2% - 1% 3.7% 6%
ROA (Net income/ Total Assets) - - 0.8% 3.1% 5%
Assets 1 - - 3,625 3,677 3,860
Book Value Per Share 2 3.270 - 3.160 3.280 3.460
Cash Flow per Share 0.6300 - - - -
Capex 1 - - 28.5 29.5 28.5
Capex / Sales - - 1.67% 1.53% 1.27%
Announcement Date 17/02/21 29/04/22 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.65 CNY
Average target price
13 CNY
Spread / Average Target
+34.72%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD. Stock Beijing Aosaikang Pharmaceutical Co., Ltd.
-10.81% 123.25Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 82TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 64TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 35TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 31TCr
ABBVIE INC. Stock AbbVie Inc.
+10.68% 30TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 24TCr
NOVARTIS AG Stock Novartis AG
+13.31% 22TCr
AMGEN INC. Stock Amgen Inc.
+8.48% 17TCr
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 16TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002755 Stock
  4. Financials Beijing Aosaikang Pharmaceutical Co., Ltd.